STTCOMP ATX FA LONG
Price of posting - 7c
MC - $27M, $10M in cash as per last quarterly
Recent raise of $13million was at 11.5c November 2024.
Have entered a position mid 7s, most sellers from today would be selling from exit liquidity (all imo)
Pharma company achieves superiority in Phase 1b/2a combination with chemotherapy alone over standalone treatment of chemo alone. Watching this one here, definitely has more left in the tank.
Definitely risky with full results expected q3 " Fifteen (15) confirmed partial responses(PRs) have now been recorded in the trial, a level of response sufficient to demonstrate that thecombination of narmafotinib and chemotherapy is superior to chemotherapy alone. "
Coming from a science background, the obvious confirmation is a result that is statistically significant (p<0.05).
Today's volume - 7million$ - at 88million shares with VWAP of 7.98. I have not seen a small cap trade like this in a while now.
